Maciag, A. E., Nandurdikar, R. S., Hong, S. Y., Chakrapani, H., Diwan, B., Morris, N. L., . . . Saavedra, J. E. (2011). Activation of the c-Jun N-terminal Kinase /Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs.
Citação norma ChicagoMaciag, Anna E., et al. Activation of the C-Jun N-terminal Kinase /Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs. 2011.
MLA citiranjeMaciag, Anna E., et al. Activation of the C-Jun N-terminal Kinase /Activating Transcription Factor 3 (ATF3) Pathway Characterizes Effective Arylated Diazeniumdiolate-Based Nitric Oxide-Releasing Anticancer Prodrugs. 2011.